639 related articles for article (PubMed ID: 21346227)
1. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
[TBL] [Abstract][Full Text] [Related]
2. Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea.
Lee JS; Oh M; ;
Clin Breast Cancer; 2014 Dec; 14(6):426-34. PubMed ID: 25034438
[TBL] [Abstract][Full Text] [Related]
3. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
[TBL] [Abstract][Full Text] [Related]
5. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study.
John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM
Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357
[TBL] [Abstract][Full Text] [Related]
6. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
7. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Duan L; Lu Y; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2017 Jan; 19(1):6. PubMed ID: 28086982
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
Ritte R; Tikk K; Lukanova A; Tjønneland A; Olsen A; Overvad K; Dossus L; Fournier A; Clavel-Chapelon F; Grote V; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Berrino F; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Weiderpass E; Dumeaux V; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; Vineis P; Merritt MA; Riboli E; Kaaks R
BMC Cancer; 2013 Dec; 13():584. PubMed ID: 24321460
[TBL] [Abstract][Full Text] [Related]
9. A Pooled Case-only Analysis of Reproductive Risk Factors and Breast Cancer Subtype Among Black Women in the Southeastern United States.
Sanderson M; Pal T; Beeghly-Fadiel A; Fadden MK; Dujon SA; Clinton C; Jimenez C; Davis J; Fortune M; Thompson J; Benson K; Conley N; Reid S; Tezak A; Shu XO; Zheng W; Blot WJ; Lipworth L
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1416-1423. PubMed ID: 33947654
[TBL] [Abstract][Full Text] [Related]
10. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study.
Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA
Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260
[TBL] [Abstract][Full Text] [Related]
11. Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study.
Figueroa JD; Davis Lynn BC; Edusei L; Titiloye N; Adjei E; Clegg-Lamptey JN; Yarney J; Wiafe-Addai B; Awuah B; Duggan MA; Wiafe S; Nyarko K; Aitpillah F; Ansong D; Hewitt SM; Ahearn T; Garcia-Closas M; Brinton LA;
Int J Cancer; 2020 Sep; 147(6):1535-1547. PubMed ID: 32068253
[TBL] [Abstract][Full Text] [Related]
12. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.
Ma H; Wang Y; Sullivan-Halley J; Weiss L; Marchbanks PA; Spirtas R; Ursin G; Burkman RT; Simon MS; Malone KE; Strom BL; McDonald JA; Press MF; Bernstein L
Cancer Res; 2010 Jan; 70(2):575-87. PubMed ID: 20068186
[TBL] [Abstract][Full Text] [Related]
13. Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women.
Chen L; Li CI; Tang MT; Porter P; Hill DA; Wiggins CL; Cook LS
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1297-304. PubMed ID: 27307466
[TBL] [Abstract][Full Text] [Related]
14. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
Yang XR; Chang-Claude J; Goode EL; Couch FJ; Nevanlinna H; Milne RL; Gaudet M; Schmidt MK; Broeks A; Cox A; Fasching PA; Hein R; Spurdle AB; Blows F; Driver K; Flesch-Janys D; Heinz J; Sinn P; Vrieling A; Heikkinen T; Aittomäki K; Heikkilä P; Blomqvist C; Lissowska J; Peplonska B; Chanock S; Figueroa J; Brinton L; Hall P; Czene K; Humphreys K; Darabi H; Liu J; Van 't Veer LJ; van Leeuwen FE; Andrulis IL; Glendon G; Knight JA; Mulligan AM; O'Malley FP; Weerasooriya N; John EM; Beckmann MW; Hartmann A; Weihbrecht SB; Wachter DL; Jud SM; Loehberg CR; Baglietto L; English DR; Giles GG; McLean CA; Severi G; Lambrechts D; Vandorpe T; Weltens C; Paridaens R; Smeets A; Neven P; Wildiers H; Wang X; Olson JE; Cafourek V; Fredericksen Z; Kosel M; Vachon C; Cramp HE; Connley D; Cross SS; Balasubramanian SP; Reed MW; Dörk T; Bremer M; Meyer A; Karstens JH; Ay A; Park-Simon TW; Hillemanns P; Arias Pérez JI; Menéndez Rodríguez P; Zamora P; Benítez J; Ko YD; Fischer HP; Hamann U; Pesch B; Brüning T; Justenhoven C; Brauch H; Eccles DM; Tapper WJ; Gerty SM; Sawyer EJ; Tomlinson IP; Jones A; Kerin M; Miller N; McInerney N; Anton-Culver H; Ziogas A; Shen CY; Hsiung CN; Wu PE; Yang SL; Yu JC; Chen ST; Hsu GC; Haiman CA; Henderson BE; Le Marchand L; Kolonel LN; Lindblom A; Margolin S; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Górski B; Gronwald J; Hooning MJ; Hollestelle A; van den Ouweland AM; Jager A; Kriege M; Tilanus-Linthorst MM; Collée M; Wang-Gohrke S; Pylkäs K; Jukkola-Vuorinen A; Mononen K; Grip M; Hirvikoski P; Winqvist R; Mannermaa A; Kosma VM; Kauppinen J; Kataja V; Auvinen P; Soini Y; Sironen R; Bojesen SE; Ørsted DD; Kaur-Knudsen D; Flyger H; Nordestgaard BG; Holland H; Chenevix-Trench G; Manoukian S; Barile M; Radice P; Hankinson SE; Hunter DJ; Tamimi R; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gaborieau V; Devilee P; Huijts PE; Tollenaar RA; Seynaeve C; Dite GS; Apicella C; Hopper JL; Hammet F; Tsimiklis H; Smith LD; Southey MC; Humphreys MK; Easton D; Pharoah P; Sherman ME; Garcia-Closas M
J Natl Cancer Inst; 2011 Feb; 103(3):250-63. PubMed ID: 21191117
[TBL] [Abstract][Full Text] [Related]
15. Aspirin use and risk of breast cancer in African American women.
Bertrand KA; Bethea TN; Gerlovin H; Coogan PF; Barber L; Rosenberg L; Palmer JR
Breast Cancer Res; 2020 Sep; 22(1):96. PubMed ID: 32887656
[TBL] [Abstract][Full Text] [Related]
16. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.
Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; Li CI
Cancer Causes Control; 2011 Mar; 22(3):399-405. PubMed ID: 21184265
[TBL] [Abstract][Full Text] [Related]
17. Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American Women.
Ambrosone CB; Zirpoli G; Hong CC; Yao S; Troester MA; Bandera EV; Schedin P; Bethea TN; Borges V; Park SY; Chandra D; Rosenberg L; Kolonel LN; Olshan AF; Palmer JR
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26085483
[TBL] [Abstract][Full Text] [Related]
18. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.
Ambrosone CB; Zirpoli G; Ruszczyk M; Shankar J; Hong CC; McIlwain D; Roberts M; Yao S; McCann SE; Ciupak G; Hwang H; Khoury T; Jandorf L; Bovbjerg DH; Pawlish K; Bandera EV
Cancer Causes Control; 2014 Feb; 25(2):259-65. PubMed ID: 24249438
[TBL] [Abstract][Full Text] [Related]
19. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.
Li CI; Beaber EF; Tang MT; Porter PL; Daling JR; Malone KE
Breast Cancer Res Treat; 2013 Jan; 137(2):579-87. PubMed ID: 23224237
[TBL] [Abstract][Full Text] [Related]
20. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
